Tuesday, February 2, 2021: Renowned healthcare entrepreneur, Dr. G.S.K. Velu has been appointed as the Chairperson of Federation of Indian Chambers of Commerce and Industry (FICCI), Tamil Nadu State Council. Prior to this, he co-chaired the FICCI Tamil Nadu State Council.
Driven by the vision to make medical technology, expertise and quality healthcare available to all, Dr. Velu has been promoting high-value health technology and diagnostics offerings through his business initiatives. Currently, he is the Chairman & Managing Director at Neuberg Diagnostics, a global pathology brand operating in India, UAE and South Africa; Chairman & Managing Director at Trivitron Healthcare, a prominent medical technology company; Mentor & Shareholder at Kauvery Group of Hospitals, a chain of multi-specialty Hospitals; Chairman at Maxivision Eye Hospitals, a national chain of eye care super-specialty hospitals; Founder & Director at Apollo White Dental & Apollo Dialysis; and Anchor Investor at Stakeboat Capital, a private equity fund. He is also the Honorary Consul to The Republic of Estonia in India, wherein the Honorary Consul jurisdiction states include Tamil Nadu, Kerala, Andhra Pradesh and Telangana.
Expressing gratitude and talking about his role, Dr. GSK Velu, Chairman and Managing Director, Neuberg Diagnostics and Trivitron Healthcare said, “I am thankful for FICCI’s vote of confidence in appointing me as the Chairperson of FICCI Tamil Nadu State Council. This position gives me an opportunity to work within the FICCI framework in meeting its objectives of industry growth at one level, and the nation’s growth at another. I look forward to engaging with industry leaders to foster an ecosystem of innovation and growth, and towards building consensus between the industry and the policymakers.”
With more than 33 years of experience in the healthcare and diagnostics industry, Dr. Velu’s contributions and prominence in the healthcare sector has been recognized and received globally. He has been bestowed with several awards and accolades which are a testimony to his hard work, dedication and, his vision of making access to affordable quality healthcare, a reality.
About Dr. GSK Velu
Dr. GSK Velu is Chairman & Managing Director at Trivitron Healthcare, the largest Indian medical technology company in the world with over 100+ Years of combined manufacturing experience, chairman, Neuberg Diagnostics, a global pathology brand that operates in India, UAE & South Africa and actively performs 6000+ varieties of pathological tests & conducts testing of over 20 million tests annually, chairman, Maxivision Eye Care Hospitals, national chain of eye care super specialty hospitals, founder and director, Apollo White Dental & Apollo Dialysis. He is also the mentor & shareholder, Kauvery Group of Hospitals, chain of multi-specialty hospitals with a presence in 6 cities with 7 Hospitals & over 1000 beds. Adding to his extensive portfolio, he is also anchor investor at Stakeboat Capital, private equity fund and GSK Ventures (Family Office Fund), that is over $100 million each, with healthcare & technology sectors and focused investment in growth markets. His vision is to make medical technology, expertise and quality healthcare available to all. He is Honorary Consul to the Republic of Estonia in India (Honorary Consul jurisdiction states – Tamil Nadu, Kerala, Andhra Pradesh and Telangana).
About Neuberg Diagnostics:
Best-in-class laboratories across India, USA, UAE & South Africa have united under the banner of Neuberg Diagnostics, to bring the latest technology and techniques within the reach of developing countries. Utilizing their combined strengths, the Neuberg Alliance brings capabilities to perform over 6000 varieties of Pathological investigations and promotes Prevention & Early Diagnosis, Focused Wellness Programs and Structured Disease Management programs for rare diseases using the most advanced technologies assisted by Data science and AI tools.
Today, Neuberg Diagnostics is among the top diagnostics companies of Indian origin and the fastest growing healthcare start-up in India. The founding members of the Neuberg consortium – Anand Diagnostic Laboratory (Bangalore), SupratechMicropath (Ahmedabad), Ehrlich Laboratory (Chennai), Global Labs (South Africa), and Minerva Diagnostics (Dubai) bring their combined heritage of over 200 years, and process over 20 million tests annually. With 10 approved labs for Covid testing, the group has processed more than 1.5 million RT PCR Tests in India and South Africa. Some of the best Pathologists, Biochemists, Geneticists, Microbiologists and several other Clinical Lab Professionals from around the world are working closely, sharing knowledge and using the latest generation of diagnostics techniques to take accurate and timely diagnosis to the next level.
Apart from the coming together of leading players, green field laboratories have been established in Cochin, Trivandrum and Hyderabad. Currently the group has 80 labs and over 100 touch points across 4 countries. Our Indian Expansion plans include setting up a network of 500 collection centers across the country within the next 12 months. Our Overseas expansion plans include establishing a presence in East Africa, West Africa, Sri Lanka, Nepal, Bangladesh, USA and Germany.
Neuberg also provides Hospital Laboratory Management Services, Preventive Health Checks, Corporate Wellness, Home Health Services and Drive through Phlebotomy Services.
About Trivitron Healthcare:
By combining innovation with affordability and accessibility, we are a leading health technology enterprise that has been operating for more than two decades to improve health and medical care throughout the world, like no one else. We consider quality healthcare a fundamental right of people and envisage to make top-notch, cutting edge healthcare technology available for people of all classes.
We lay great emphasis on research and development. Our team includes internationally acclaimed experts and leading scientists who innovate unprecedented health technologies suitable for healthcare needs of today and tomorrow.
We provide technological advancements to hospitals, individual healthcare providers, independent clinics, extended care facilities and laboratories, catering to healthcare needs in multiple verticals like In-Vitro Diagnostics (IVD), Medical Imaging & Radiology (In-vivo Diagnostics), Critical Care & OT Solutions, Newborn screening (NBS) and Radiation Protection Apparels (RPA).
Through a growing network of 1500+ employees, 1200+ channel partners and 13 world-class manufacturing units in India, Finland, Turkey & China, Trivitron Healthcare is reaffirming its commitment to offer superior health technologies in 180+ countries saving lives and improving care.
By simplifying and expanding our business, we are rapidly moving to establish ourselves as a global leader in health technology. We are committed to build a sustainable business that delivers value by offering best available health technology solutions for millions of people worldwide.
www.trivitron.com | corporate@trivitron.com
For further details, please contact:
| Mona Surani
Perfect Relations 98206 94705 |
Nitheen AS
Perfect Relations 96862 27227 |
